Waveform Analysis In Snakebite Victims With Hematotoxicity
NCT ID: NCT03859154
Last Updated: 2023-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2022-03-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Activated partial thromboplastin time (aPTT) based Clot Waveform Analysis (CWA) is an optic absorbance assay that can be used as a global clotting test.
It essentially detects the change in colour of the plasma as coagulation progresses and quantifies the change in the form of a waveform.
In this study, the investigators intend to study prospectively the behaviour of clot wave (CW) in hematotoxic bites.
A pilot observational study was initially conducted (IEC Ref No. 42/16/IEC/JMMC and RI) and CWA showed changes which provided information earlier than the conventional coagulation studies in the snakebite victims studied.
While aPTT or WBCT reflects clotting time, CWA conveys the dynamic process of clot formation. CWA may reveal disorders of clotting in snakebite victims before the conventional tests become abnormal.
Here the investigators aim to study the changes in CWA in snakebite victims who develop coagulation disorders in blood
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemostatic Variables In Snakebite Study
NCT04520282
Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome
NCT04845022
California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
NCT03469947
Global Hemostasis Monitoring by Using Sonoclot Signature in Traumatic Patients
NCT04100395
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma
NCT03280212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In hematotoxic bites, the test recommended to ascertain the development of coagulopathy is a whole blood clotting test (WBCT) as per the current guidelines.
Eventhough the reliability and sensitivity of WBCT has been shown to be low, it still remains the standard test.
There exists a need to explore other coagulation studies in snakebite to look for a better and efficient alternative.
Clot waveform analysis (CWA) is an activated partial thromboplastin time (aPTT)-based optic absorbance assay that can be used as a global clotting test.
It has been shown useful in identifying disseminated intravascular coagulation (DIC) in sepsis with high specificity (97.6%) and sensitivity (98%), and the test is recommended by the British Committee for Standards in Hematology guidelines for the diagnosis and treatment of DIC.
CWA is based on the traditional aPTT assay. On assessing aPTT with light transmission, a change in the light absorbance is observed as the clot stabilizes by fibrin polymerization.
Plotting the milliabsorbance (mAbs) of the sample to time, a curve is obtained which reflects the optical profile that is generated as a clot is formed.
This tracing against time gives a qualitative assessment of fibrin polymerization.
The delta in absorbance (dAbs) is based on the change in mAbs value from the baseline to the endpoint (plateau) along the Y-axis of the clot curve. The dAbs values of \<100 mAbs denote low fibrinogen samples
The normal clot waveform has five main phases: delay, baseline, acceleration, deceleration, and end point.
The "delay" period begins at 0 and precedes the "baseline." which denotes the mixing of the reagents and system optimization of light intensity.
The "baseline" is the portion of the curve which appears after all reagents have been added to the time and the clot formation begins.
The aPTT value is noted at this point (vertical red line). The "acceleration" phase denotes fibrin clot formation, whereas "deceleration" denotes decreasing rate of clot formation.
There are two more curves that are plotted in CWA, the first derivative and the second derivatives. They are both derivatives of the absorbance curves. The first derivative reflects the coagulation velocity, whereas the second derivative reflects the acceleration of coagulation.
The investigators in this study aim to assess the changes in the CW form in viper-envenomated victims and to compare CWA with standard tests such as prothrombin time (PT) with the international normalized ratio (INR), aPTT, clotting time (CT) (modified Lee and White method) and 20'WBCT( twenty minute whole blood clotting test)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Viper bite victims
Snakebite victims in whom the snake has been brought and positively identified as Viperidae AND simultaneous aPTT has been sent AND consenting to be part of the study
No interventions assigned to this group
Nonvenomous snakebite
age and gender matched victims of snake bite in whom the culprit snake brought along has been identified as a non venomous one.
AND consenting to be part of the study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* OR known case of coagulation disorders
* OR chronic liver disease
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jubilee Mission Medical College and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Siju V Abraham, MD
Assistant Professor in the Department of Emergency Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Siju V Abraham, M.D
Role: PRINCIPAL_INVESTIGATOR
Jubilee Mission Medical College and Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jubilee Mission Medical College and Research Institute
Thrissur, Kerala, India
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abraham SV, Rafi AM, Krishnan SV, Palatty BU, Innah SJ, Johny J, Varghese S. Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity. J Emerg Trauma Shock. 2018 Jul-Sep;11(3):211-216. doi: 10.4103/JETS.JETS_43_17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1229-0385
Identifier Type: OTHER
Identifier Source: secondary_id
05/19/IEC/JMMC&RI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.